<DOC>
	<DOCNO>NCT02705534</DOCNO>
	<brief_summary>The investigator treat 50 patient cirrhosis due hepatitis C genotype 1 , sofosbuvir 400 mg daily , ledipasvir 90 mg daily weight-based ribavirin ( 1000 mg/d &lt; 75 kg , 1200 mg/d &gt; 75 kg , divide two daily dos ) 12 week calculate sustain viral response rate 12 week .</brief_summary>
	<brief_title>Sofosbuvir , Ledipasvir , Ribavirin Hepatitis C Cirrhotics , Genotype 1</brief_title>
	<detailed_description>Cirrhosis due Hepatitis C virus ( HCV ) present rather difficult treatment problem many tolerate interferon , previous standard care . The new direct acting antiviral provide patient new hope . One combination sofosbuvir ( SOF ) 400 mg ledipasvir ( LDV ) 90 mg give daily without weight-based ribavirin ( RBV ) 12 24 week HCV genotype 1 patient . The current recommendation cirrhotics ( genotype 1 ) SOF/LDV/RBV 24 week recommendation base lack data short period . In order evaluate response rate combination SOF/LDV/RBV investigator decide treat 50 HCV genotype 1 cirrhotics combination 12 week . Patients MELD score &gt; 20 exclude . The investigator calculate sustain viral response rate 12 week ( SVR12 ) .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<criteria>Positive qualitative hepatitis C RNA polymerase chain reaction assay two occasion least 6 month apart Renal failure [ estimate glomerular filtration rate ( eGFR ) &lt; 30 cc/min ] , Model End stage Liver Disease ( MELD ) score &gt; 20 , Child 's class C ( score &gt; 12 ) , Heart rate &lt; 50/min , Taking amiodarone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Cirrhosis</keyword>
	<keyword>Sofosbuvir</keyword>
	<keyword>Ledipasvir</keyword>
	<keyword>Ribavirin</keyword>
</DOC>